Description: Most Medicare Advantage enrollees say the extra perks offered by their plans are important, but less than half are taking advantage, a new study finds.

Description: The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Description: UnitedHealth pushes its hybrid care model forward, merging digital tools with in-person care as it extends this approach across global markets.

Description: Wondering if Humana stock is actually a bargain, or if it just looks like one after its recent slide? You are not alone in questioning whether now is a buying opportunity or a value trap. Humana’s share price has dropped sharply, down 21.1% over the last month and nearly 23% in the past year. This signals shifting market sentiment and a newly skeptical investor base. Recent headlines have highlighted major changes in the healthcare landscape. Insurers like Humana are under increased scrutiny...

Description: LOUISVILLE, Ky., November 20, 2025--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.

Description: HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total pol

Description: LOUISVILLE, Ky., November 19, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in Kentucky: A Growing Public Health Challenge. The brief examines the complex web of challenges the state’s older adults face in accessing nutritious foods and offers a call to action with recommended investments that can help overcome those barriers.

Description: Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities rallied in the third quarter, driven by AI enthusiasm, resilient corporate earnings, the first U.S. rate cut of the year, and targeted policy easing across key regions. Against this […]

Description: In early November 2025, Humana Inc. reported third quarter results showing increased revenue to US$32.65 billion, but net income dropped to US$195 million compared to the previous year. The company also completed a US$200 million share buyback and revised its 2025 annual earnings guidance downward to approximately US$12.26 per share. One standout detail is that while revenue continued to rise both in the quarter and year-to-date, Humana’s profitability faced headwinds, leading to a sizable...

Description: LOUISVILLE, Ky., November 18, 2025--CenterWell Home Health branches collect 287,000 meals for needy.

Description: LOUISVILLE, Ky., November 18, 2025--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.

Description: Routine dental work, vision and long-term care costs can be substantial.

Description: CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.

Description: UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Description: Although Humana has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Description: Exploring the Strategic Moves in Chris Davis (Trades, Portfolio)'s Third Quarter 2025 13F Filing

Description: Humana (HUM) shares have seen a modest drop of 5% over the past month, following some turbulence in the healthcare sector. Investors are weighing recent returns alongside the company’s steady annual revenue and income growth. See our latest analysis for Humana. This latest 1-month share price return of -14.9% has knocked some momentum out of Humana, as broader market jitters and sector headwinds linger. With a total shareholder return of -14.4% over the last year, the stock’s longer-term...

Description: Companies in The News Are: TSN, VG, AAL, HUM

Description: Stocks rallied after the Senate advanced a measure designed to end the government shutdown. Magnificent Seven companies and other technology stocks led the way. The Nasdaq composite gained 2.3%, while the S&P 500 rose 1.5% and the Dow industrials climbed 0.8%.

Description: Wall Street was buoyed by investor optimism that the longest federal government shutdown in U.S. history could be nearing an end.

Description: LOUISVILLE, Ky., November 10, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and nutrition programs in four states. The funding will help address urgent needs in communities where the loss of food assistance for nearly 42 million Americans, have intensified food insecurity. These and other economic challenges have contributed to a sharp rise in demand for food support.

Description: Also: All the news and watercooler chat from Fortune.

Description: In a conversation with Fortune, Rechtin said the health-insurance giant that primarily serves seniors is "not where we want to be."

Description: LOUISVILLE, Ky., November 06, 2025--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time.

Description: Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Description: Humana Inc (HUM) maintains a strong EPS outlook while focusing on operational efficiencies and strategic acquisitions to enhance growth and service quality.

Description: Shares in AMD rise after the chip maker posts better-than-expected third-quarter earnings and revenue.

Description: Shares of health insurance company Humana (NYSE:HUM) fell 8.4% in the morning session after the company's third-quarter earnings report revealed a significant miss on profit estimates, fueling concerns about declining profitability. While the company reported revenue of $32.65 billion, beating analysts' expectations, its GAAP earnings per share (EPS) of $1.62 came in 43.4% below the consensus estimate of $2.86. The pressure on profitability was evident as Humana's operating margin fell to 1.2%,

Description: Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 0.5% and the Health

Description: HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.

Description: Humana Inc. ( NYSE:HUM ) will pay a dividend of $0.885 on the 30th of January. This payment means the dividend yield...

Description: The insurer reports better-than-expected quarterly earnings and reaffirms its full-year adjusted earnings guidance.

Description: Strong Private Payrolls for October.

Description: ADP marked an improvement of +20K above expectations and a swing to the positive from an upwardly revised -29K the prior month.

Description: Yahoo Finance Senior Reporter Allie Canal takes a look at some of Wednesday's trending tickers and stories. Rivian (RIVN) beat on third quarter earnings results. Humana (HUM) stock is under pressure after the company warned that medical costs are higher than usual. Unity Software (U) stock is surging after the company released third quarter results that beat expectations. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: Health insurance company Humana (NYSE:HUM) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 11.4% year on year to $32.65 billion. The company expects the full year’s revenue to be around $128 billion, close to analysts’ estimates. Its GAAP profit of $1.62 per share was 43.4% below analysts’ consensus estimates.

Description: The main US stock measures were tracking in the red in Wednesday's premarket activity as traders awa

Description: Humana (HUM) delivered earnings and revenue surprises of +11.34% and +2.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to rise, dragging down margins for its core Medicare Advantage business.

Description: Investing.com - Humana has said it expects a decline of membership in its full-year individual Medicare Advantage plans to be lower than previously anticipated, but slashed its unadjusted profit outlook amid heightened medical care costs.

Description: HUM) on Wednesday reported third-quarter profit of $195 million. On a per-share basis, the Louisville, Kentucky-based company said it had profit of $1.62. Earnings, adjusted for non-recurring costs, came to $3.24 per share.

Description: LOUISVILLE, Ky., November 05, 2025--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.

Description: The Medicare giant likes what it’s seen in the first two weeks of open enrollment. But there are steps it can take if membership growth starts getting out of hand, executives said.

Description: The numbers will come at the tail end of what has been a bumpy earnings season for the large managed-care companies.

Description: Humana (HUM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Description: Humana and USAA Life recently reaffirmed their partnership to continue co-branded Medicare Advantage plans for 2026, announcing the introduction of new mental health benefits including $0 copays for in-network services, with the announcement occurring in late October 2025. This collaboration is designed to support veterans’ mental and physical health, highlighting Humana’s focus on social impact, expanded care, and innovation in insurance coverage. We'll now explore how the expanded...

Description: Curious whether Humana is a hidden gem or an overhyped pick? You are not alone, and we are about to dive deep into what the numbers say about its true worth. Humana’s stock price has seen a slight dip of 4.2% over the past week, though it is still up a notable 10.8% year to date and 11.1% over the last year, hinting at renewed optimism despite recent volatility. Much of this recent movement has been driven by headlines around industry shake-ups and regulatory changes impacting healthcare...

Description: Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.

Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Description: The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Description: The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Description: Select Medical (SEM) delivered earnings and revenue surprises of +27.78% and +2.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Description: UnitedHealth Group's (UNH) stock hasn't received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.

Description: Cigna has outperformed peers as the managed-care industry faces policy challenges. Affordable Care Act subsidies are set to expire and premiums for next year are up 26%.

Description: On Tuesday, UnitedHealth Group Chief Executive Stephen Hemsley told investors the company is “positioning for durable and accelerating growth in 2026 and beyond.” One way it is doing that: cutting its Medicare business down to size. Bobby Hunter, who oversees UnitedHealth care’s government programs, said the insurer expects its Medicare membership to fall by about one million members next year.

Description: Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE: HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership is designed to advance quality of care and help optimize patient health outcomes for eligible individuals living wit

Description: UnitedHealth Group stock rose Tuesday after a slightly better-than-expected quarter for the company’s health insurance division led to a modest earnings beat. The stock jumped more than 4% in the premarket hours, a surprisingly big jump given the results, which were largely in line with expectations. It was an indication of Wall Street’s eagerness to see signs of recovery in the stock, which suffered a historic selloff this spring.

Description: Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Description: Altius, the AI-powered wellbeing infrastructure company led by former Humana and Walmart executives Timothy State and David Hoke, today announced a multi-year exclusive partnership with Syd Life AI, the UK-based pioneer in preventive health technologies, to launch its personalized LLM in the United States.

Description: UnitedHealth (UNH) delivered earnings and revenue surprises of +6.18% and -0.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: LOUISVILLE, Ky., October 28, 2025--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025.

Description: CNC braces for Q3 results as revenue growth may be offset by rising medical costs and shrinking Medicaid memberships.

Description: Humana (OM:HUM) reported net profit margins of 2%, an increase from 1.1% a year ago, and delivered a sharp year-on-year earnings growth of 93.6% after several years of declines averaging 12.2% per year. The company’s stock currently trades at SEK46, notably below its estimated fair value of SEK163.72, while its price-to-earnings ratio stands at just 10.8x compared to industry averages of 18.9x and 27.2x for peers. Looking ahead, analysts forecast earnings growth of 12.8% per year, outpacing...

Description: UNH's Q3 results hinge on premium growth and Optum gains amid rising costs and margin pressure.

Description: LOUISVILLE, Ky., October 23, 2025--Following World Mental Health Day, the Humana Foundation – the philanthropic arm of Humana Inc. for the past 44 years – along with Jewish Heritage Fund and the University of Louisville’s Christina Lee Brown Envirome Institute, announced the grand opening of the new "Health and Well-being Center" at Junior Achievement (JA) Finance Park of Kentucky. The milestone was marked with a ribbon-cutting ceremony at the Park.

Description: Humana (HUM) shares have seen steady gains over the past month, climbing 12%. Investor sentiment seems to be improving as the company posts solid yearly revenue and net income growth in its latest financials. See our latest analysis for Humana. After this strong run over the past month, Humana’s momentum is unmistakable. The stock has notched an 11.6% share price return in 30 days and is now up nearly 14% year-to-date. While the 12.8% total shareholder return over the past year signals...

Description: MIAMI, October 22, 2025--CarePlus announces Medicare Advantage plan offerings for 2026.

Description: Humana's sharper Medicare focus, cost discipline and leaner structure position it ahead of UnitedHealth in the healthcare stock race.

Description: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Description: Humana is scheduled to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings fall.

Description: LOUISVILLE, Ky., October 21, 2025--Humana announces 2026 Medicare Advantage plans designed with veterans in mind. Humana USAA Honor Giveback Plans elevate mental health support.

Description: Shares of health insurance company Humana (NYSE:HUM) jumped 2.3% in the morning session after the company announced a new initiative with Providence, a Washington-based health system, to streamline and secure data exchange in support of value-based care. The collaboration aimed to create a scalable system for seamless data sharing, enabling clinicians to deliver more effective care while reducing administrative tasks for members. Humana's President of Insurance, George Renaudin, stated that the

Description: LOUISVILLE, Ky., October 20, 2025--Humana and Providence launch innovative data exchange collaboration to advance value-based care.

Description: Thinking about what to do with Cigna Group stock right now? You are not alone. Investors have been watching the company’s price movements closely, especially after a rollercoaster year that saw shares climb an impressive 76.3% over five years but fall 9.2% in the past twelve months. This kind of long-term bounce paired with recent softening leaves many asking if there is still value in the stock, or if risks have started to outweigh rewards. Dig a little deeper and the story gets even more...

Description: Millions of seniors with Medicare Advantage plans can expect slimmed-down benefits, loftier premiums, and a reduced selection of options in 2026 plans.

Description: Earlier this week, a Texas judge ruled against Humana in a legal challenge, upholding government-imposed downgrades to Medicare Advantage quality star ratings and confirming cuts to related bonus payments, which could impact billions of dollars in revenue for the company. This court decision introduces significant uncertainty for Humana’s core Medicare Advantage business, as quality ratings are a key factor in determining government reimbursement rates. We'll examine how this legal setback...

Description: Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.

Description: The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Description: Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Description: Here is how Beam Therapeutics Inc. (BEAM) and Humana (HUM) have performed compared to their sector so far this year.